Tofacitinib Shows Promise for Treating Severe Alopecia Areata Tofacitinib Shows Promise for Treating Severe Alopecia Areata

The Janus kinase (JAK) inhibitor tofacitinib shows promise for treating severe alopecia areata and its variants in adults and adolescents, according to two retrospective studies.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news